BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28344197)

  • 1. Effects of Food on the Pharmacokinetics of Omega-3-Carboxylic Acids in Healthy Japanese Male Subjects: A Phase I, Randomized, Open-label, Three-period, Crossover Trial.
    Shimada H; Nilsson C; Noda Y; Kim H; Lundström T; Yajima T
    J Atheroscler Thromb; 2017 Sep; 24(9):980-987. PubMed ID: 28344197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of Single and Multiple Doses of Omega-3 Carboxylic Acids in Healthy Chinese Subjects: A Phase I, Open-Label Study.
    Jing S; Zhang Z; Chen X; Miao R; Nilsson C; Lin Y
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):985-994. PubMed ID: 32567203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Omega-3 fatty acid exposure with a low-fat diet in patients with past hypertriglyceridemia-induced acute pancreatitis; an exploratory, randomized, open-label crossover study.
    Dunbar RL; Gaudet D; Davidson M; Rensfeldt M; Yang H; Nilsson C; Kvarnström M; Oscarsson J
    Lipids Health Dis; 2020 May; 19(1):117. PubMed ID: 32473640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II study.
    Offman E; Marenco T; Ferber S; Johnson J; Kling D; Curcio D; Davidson M
    Vasc Health Risk Manag; 2013; 9():563-73. PubMed ID: 24124374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Bioavailability and Dose Proportionality of Omega-3 Administered in Free Fatty Acid Form Compared With Ethyl Ester Form: Results of a Phase 1 Study in Healthy Volunteers.
    Offman E; Davidson M; Abu-Rashid M; Chai P; Nilsson C
    Eur J Drug Metab Pharmacokinet; 2017 Oct; 42(5):815-825. PubMed ID: 28116646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Single-dose, Comparative Bioavailability Study of a Formulation containing OM3 as Phospholipid and Free Fatty Acid to an Ethyl Ester Formulation in the Fasting and Fed States.
    Lapointe JF; Harvey L; Aziz S; Jordan H; Hegele RA; Lemieux P
    Clin Ther; 2019 Mar; 41(3):426-444. PubMed ID: 30799231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a Self-micro-emulsifying Delivery System Formulation Versus a Standard ω-3 Acid Ethyl Ester Product on the Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid: A Study in Healthy Men and Women in a Fasted State.
    Maki KC; Palacios OM; Buggia MA; Trivedi R; Dicklin MR; Maki CE
    Clin Ther; 2018 Dec; 40(12):2065-2076. PubMed ID: 30454850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel self-micro-emulsifying delivery system (SMEDS) formulation significantly improves the fasting absorption of EPA and DHA from a single dose of an omega-3 ethyl ester concentrate.
    Qin Y; Nyheim H; Haram EM; Moritz JM; Hustvedt SO
    Lipids Health Dis; 2017 Oct; 16(1):204. PubMed ID: 29037249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety, Tolerability, and Pharmacokinetics of Single and Multiple Oral Doses of an Omega-3-Carboxylic Acid Formulation in Healthy Male Japanese Subjects: A Phase 1 Single-Blind, Randomized, Placebo-Controlled Trial.
    Noda Y; Nilsson C; Shimada H; Kim H; Lundström T; Yajima T
    Clin Pharmacol Drug Dev; 2018 Feb; 7(2):177-187. PubMed ID: 28597973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers.
    Rusca A; Di Stefano AF; Doig MV; Scarsi C; Perucca E
    Eur J Clin Pharmacol; 2009 May; 65(5):503-10. PubMed ID: 19148629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal food effect for eicosapentaenoic acid and docosahexaenoic acid bioavailability from omega-3-acid ethyl esters with an Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak AA; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    J Clin Lipidol; 2017; 11(2):394-405. PubMed ID: 28502496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova(®) compared to Lovaza(®) in a pharmacokinetic single-dose evaluation) study.
    Davidson MH; Johnson J; Rooney MW; Kyle ML; Kling DF
    J Clin Lipidol; 2012; 6(6):573-84. PubMed ID: 23312053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid Technologies
    Lopez-Toledano MA; Thorsteinsson T; Daak A; Maki KC; Johns C; Rabinowicz AL; Sancilio FD
    Clin Ther; 2017 Mar; 39(3):581-591. PubMed ID: 28189364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability of long chain omega-3 polyunsaturated fatty acids from phospholipid-rich herring roe oil in men and women with mildly elevated triacylglycerols.
    Cook CM; Hallaråker H; Sæbø PC; Innis SM; Kelley KM; Sanoshy KD; Berger A; Maki KC
    Prostaglandins Leukot Essent Fatty Acids; 2016 Aug; 111():17-24. PubMed ID: 27151222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of OM3-PL/FFA Pharmacokinetics After Single and Multiple Oral Doses in Healthy Volunteers.
    Lapointe JF; Harvey L; Aziz S; Hegele RA; Lemieux P
    Clin Ther; 2019 Dec; 41(12):2500-2516. PubMed ID: 31679821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology of dietary supplements.
    Galli C; Maggi FM; Risé P; Sirtori CR
    Br J Clin Pharmacol; 2012 Jul; 74(1):60-5. PubMed ID: 22242645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial comparing omega-3 fatty acid plasma levels after ingestion of emulsified and non-emulsified cod liver oil formulations.
    Conus N; Burgher-Kennedy N; van den Berg F; Kaur Datta G
    Curr Med Res Opin; 2019 Apr; 35(4):587-593. PubMed ID: 30106311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies to improve bioavailability of omega-3 fatty acids from ethyl ester concentrates.
    Maki KC; Dicklin MR
    Curr Opin Clin Nutr Metab Care; 2019 Mar; 22(2):116-123. PubMed ID: 30550388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of omega-3 carboxylic acids to statin therapy in patients with persistent hypertriglyceridemia.
    Davidson MH; Phillips AK; Kling D; Maki KC
    Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1045-54. PubMed ID: 25089906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of manufactured foods enriched with fish oils as a means of increasing long-chain n-3 polyunsaturated fatty acid intake.
    Lovegrove JA; Brooks CN; Murphy MC; Gould BJ; Williams CM
    Br J Nutr; 1997 Aug; 78(2):223-36. PubMed ID: 9301413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.